Inogen, Inc (NASDAQ:INGN – Get Free Report) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $6.93 and traded as high as $7.74. Inogen ...

Inogen's new management and strategy are yielding results, with better-than-expected 2024 performance and a more stable base from which to keep growing the B2B business. Despite weak DTC sales, strong ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...

Inogen will be reporting Q4 earnings on February 23. Analysts expect Inogen will release losses per share of $0.574. Go here to follow Inogen stock price in real-time ahead of earnings. On February 23 ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results ...

Inogen (INGN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Inogen's price performance has been poor this year, but a closer look at the numbers suggests that the market's negativity may be unwarranted. Management is actively taking steps to address the ...

Inogen Inc (NASDAQ:INGN), a medical technology company, reported fourth-quarter 2023 revenues of $75.90 million, missing the consensus of $76.99 million. Fourth quarter total revenue fell from $88.1 ...

Three health-care companies set estimated price ranges for their proposed initial public offerings Tuesday, edging closer to joining the long and growing list of such companies hitting public markets.